搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Anaeromyxobacter sp. ATP phosphoribosyltransferase regulatory subunit (hisZ) CSB-YP416933AUT
CSB-EP416933AUT
CSB-BP416933AUT
CSB-MP416933AUT
CSB-EP416933AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. V-type ATP synthase alpha chain (atpA), partial CSB-YP416934AUT
CSB-EP416934AUT
CSB-BP416934AUT
CSB-MP416934AUT
CSB-EP416934AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP416935AUT
CSB-EP416935AUT
CSB-BP416935AUT
CSB-MP416935AUT
CSB-EP416935AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. Non-canonical purine NTP pyrophosphatase (Anae109_3424) CSB-YP416936AUT
CSB-EP416936AUT
CSB-BP416936AUT
CSB-MP416936AUT
CSB-EP416936AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. Recombination protein RecR (recR) CSB-YP416937AUT
CSB-EP416937AUT
CSB-BP416937AUT
CSB-MP416937AUT
CSB-EP416937AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP416938AUT
CSB-EP416938AUT
CSB-BP416938AUT
CSB-MP416938AUT
CSB-EP416938AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. Urease subunit alpha (ureC), partial CSB-YP416939AUT
CSB-EP416939AUT
CSB-BP416939AUT
CSB-MP416939AUT
CSB-EP416939AUT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter sp. Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP416940AUT1
CSB-EP416940AUT1
CSB-BP416940AUT1
CSB-MP416940AUT1
CSB-EP416940AUT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Dihydrodipicolinate synthase (dapA) CSB-YP416941FDS
CSB-EP416941FDS
CSB-BP416941FDS
CSB-MP416941FDS
CSB-EP416941FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP416942FDS
CSB-EP416942FDS
CSB-BP416942FDS
CSB-MP416942FDS
CSB-EP416942FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Ribosome-binding factor A (rbfA) CSB-YP416943FDS
CSB-EP416943FDS
CSB-BP416943FDS
CSB-MP416943FDS
CSB-EP416943FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum UPF0173 metal-dependent hydrolase Fnod_0635 (Fnod_0635) CSB-YP416944FDS
CSB-EP416944FDS
CSB-BP416944FDS
CSB-MP416944FDS
CSB-EP416944FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Glutamate--tRNA ligase 1 (gltX1) CSB-YP416945FDS
CSB-EP416945FDS
CSB-BP416945FDS
CSB-MP416945FDS
CSB-EP416945FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Methylenetetrahydrofolate--tRNA- (uracil-5-)-methyltransferase TrmFO CSB-YP416946FDS
CSB-EP416946FDS
CSB-BP416946FDS
CSB-MP416946FDS
CSB-EP416946FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum Flagellar P-ring protein (flgI) CSB-YP416947FDS
CSB-EP416947FDS
CSB-BP416947FDS
CSB-MP416947FDS
CSB-EP416947FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum 50S ribosomal protein L34 (rpmH) CSB-YP416948FDS
CSB-EP416948FDS
CSB-BP416948FDS
CSB-MP416948FDS
CSB-EP416948FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum 30S ribosomal protein S11 (rpsK) CSB-YP416949FDS
CSB-EP416949FDS
CSB-BP416949FDS
CSB-MP416949FDS
CSB-EP416949FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum 30S ribosomal protein S5 (rpsE) CSB-YP416950FDS
CSB-EP416950FDS
CSB-BP416950FDS
CSB-MP416950FDS
CSB-EP416950FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum 50S ribosomal protein L14 (rplN) CSB-YP416951FDS
CSB-EP416951FDS
CSB-BP416951FDS
CSB-MP416951FDS
CSB-EP416951FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fervidobacterium nodosum 30S ribosomal protein S3 (rpsC) CSB-YP416952FDS
CSB-EP416952FDS
CSB-BP416952FDS
CSB-MP416952FDS
CSB-EP416952FDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>